Michael Smith

3.1k total citations
68 papers, 2.0k citations indexed

About

Michael Smith is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Michael Smith has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Immunology and 10 papers in Surgery. Recurrent topics in Michael Smith's work include Immunotherapy and Immune Responses (9 papers), Cervical Cancer and HPV Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Michael Smith is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cervical Cancer and HPV Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Michael Smith collaborates with scholars based in United States, United Kingdom and Canada. Michael Smith's co-authors include Mark A. Tomai, István Arany, Herbert B. Slade, Margaret Stanley, Richard L. Miller, Daniel McDermott, Stephen K. Tyring, Joyce Taylor‐Papadimitriou, Joy Burchell and Rosalind Graham and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Smith

66 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Smith United States 25 504 433 309 293 288 68 2.0k
Jyotirmay Biswas India 33 761 1.5× 224 0.5× 402 1.3× 483 1.6× 478 1.7× 354 4.4k
Giuseppe Tridente Italy 29 353 0.7× 926 2.1× 413 1.3× 184 0.6× 178 0.6× 129 2.6k
Maurice R.G. O’Gorman United States 31 473 0.9× 880 2.0× 258 0.8× 191 0.7× 128 0.4× 104 2.7k
N Kirkham United Kingdom 22 307 0.6× 302 0.7× 828 2.7× 234 0.8× 179 0.6× 83 2.0k
John R. Davis United States 31 528 1.0× 173 0.4× 478 1.5× 315 1.1× 370 1.3× 93 2.9k
Sigrun Smola Germany 25 684 1.4× 548 1.3× 552 1.8× 173 0.6× 102 0.4× 82 2.0k
Ping Zhang China 28 256 0.5× 432 1.0× 255 0.8× 254 0.9× 162 0.6× 140 2.8k
Peter Wu United States 31 305 0.6× 220 0.5× 333 1.1× 815 2.8× 473 1.6× 87 2.6k
Michael Schmidt Germany 33 931 1.8× 694 1.6× 484 1.6× 234 0.8× 318 1.1× 144 4.0k
Georgi Tchernev Bulgaria 25 582 1.2× 163 0.4× 418 1.4× 310 1.1× 252 0.9× 339 2.2k

Countries citing papers authored by Michael Smith

Since Specialization
Citations

This map shows the geographic impact of Michael Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Smith more than expected).

Fields of papers citing papers by Michael Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Smith. The network helps show where Michael Smith may publish in the future.

Co-authorship network of co-authors of Michael Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Smith. A scholar is included among the top collaborators of Michael Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Smith. Michael Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Münster, Pamela N., Nicholas Iannotti, Daniel C. Cho, et al.. (2023). Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer Research Communications. 3(12). 2572–2584. 5 indexed citations
2.
Luke, Jason J., Marwan Fakih, Charles Schneider, et al.. (2023). Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors. British Journal of Cancer. 128(12). 2227–2235. 19 indexed citations
3.
Naing, Aung, John D. Powderly, John Nemunaitis, et al.. (2022). Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. Journal for ImmunoTherapy of Cancer. 10(3). e004223–e004223. 12 indexed citations
4.
Fink, Corby, Michael Smith, Jeffrey M. Gaudet, et al.. (2020). Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model. Diagnostic and Interventional Imaging. 101(9). 577–588. 6 indexed citations
5.
Fink, Corby, Michael Smith, Jeffrey M. Gaudet, et al.. (2019). Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response. Molecular Imaging and Biology. 22(3). 549–561. 24 indexed citations
6.
Smith, Michael. (2018). The Importance of Multiple Perspectives in Psychiatry. 1(3). 1 indexed citations
7.
Fink, Corby, Jeffrey M. Gaudet, Matthew S. Fox, et al.. (2018). 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting. Scientific Reports. 8(1). 590–590. 41 indexed citations
8.
Krishna, Vinay, et al.. (2017). Telehealth in the Delivery of Home Dialysis Care: Catching up With Technology. Advances in Chronic Kidney Disease. 24(1). 12–16. 32 indexed citations
9.
Hartkamp, Linda M., Jay S. Fine, Inge E. van Es, et al.. (2014). Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants. Annals of the Rheumatic Diseases. 74(8). 1603–1611. 38 indexed citations
10.
Altorki, Nasser K., Rowena Yip, Takaomi Hanaoka, et al.. (2013). Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. Journal of Thoracic and Cardiovascular Surgery. 147(2). 754–764. 243 indexed citations
11.
Bennell, Kim L., Rana S. Hinman, Ben Metcalf, et al.. (2003). Relationship of knee joint proprioception to pain and disability in individuals with knee osteoarthritis. Journal of Orthopaedic Research®. 21(5). 792–797. 117 indexed citations
12.
Boon, Heather, Ethan Basch, Steve Bent, et al.. (2002). Horse Chestnut. Journal of Herbal Pharmacotherapy. 2(1). 71–85. 14 indexed citations
13.
Fife, Kenneth H., Alex Ferenczy, John M. Douglas, et al.. (2001). Treatment of External Genital Warts in Men Using 5% Imiquimod Cream Applied Three Times a Week, Once Daily, Twice Daily, or Three Times a Day. Sexually Transmitted Diseases. 28(4). 226–231. 52 indexed citations
14.
Vasilakos, John P., et al.. (2000). Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN. Cellular Immunology. 204(1). 64–74. 124 indexed citations
15.
Langley, Paul C., S K Tyring, & Michael Smith. (1999). The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.. PubMed. 5(1). 69–77. 25 indexed citations
16.
Gilson, Richard, Jerome L. Shupack, Alvin E. Friedman‐Kien, et al.. (1999). A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS. 13(17). 2397–2404. 65 indexed citations
17.
Arany, István, Stephen K. Tyring, Margaret Stanley, et al.. (1999). Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Research. 43(1). 55–63. 100 indexed citations
18.
Carr-Brendel, Victoria, Dubravka Marković, Michael Smith, Joyce Taylor‐Papadimitriou, & Edward P. Cohen. (1999). Immunity to Breast Cancer in Mice Immunized with X-Irradiated Breast Cancer Cells Modified to Secrete IL-12. Journal of Immunotherapy. 22(5). 415–422. 9 indexed citations
19.
Tyring, Stephen K., István Arany, Margaret Stanley, et al.. (1998). A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod. The Journal of Infectious Diseases. 178(2). 551–555. 199 indexed citations
20.
Smith, Michael. (1953). Familial Incidence of Sialectasis. BMJ. 2(4850). 1359–1359. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jyotirmay Biswas Breakdown of academic impact, for papers by Giuseppe Tridente Breakdown of academic impact, for papers by Maurice R.G. O’Gorman Breakdown of academic impact, for papers by N Kirkham Breakdown of academic impact, for papers by John R. Davis Breakdown of academic impact, for papers by Sigrun Smola Breakdown of academic impact, for papers by Ping Zhang Breakdown of academic impact, for papers by Peter Wu Breakdown of academic impact, for papers by Michael Schmidt Breakdown of academic impact, for papers by Georgi Tchernev
Rankless by CCL
2026